BioSpace News Archive

Two days after unveiling an executive order to boost U.S. biomanufacturing, the White House unveiled plans that include $2 billion to support the initiative.

Biopharma and life science companies added changes to their leadership teams this week, with Cara Therapeutics, SOTIO Biotech, Agenus, and more filling several C-suite positions.

Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius”) and Cend Therapeutics, Inc. (“Cend”) today announced that the proposed merger of the two companies has closed following the approval of Caladrius’ stockholders on September 13, 2022.

20/20 Imaging, a division of Konica Minolta Healthcare Americas, Inc., announces the FDA clearance of the Chiropractic Straight Arm (CSA) system with Dynamic Digital Radiography (DDR). DDR is Konica Minolta’s revolutionary X-ray technology enabling the visualization of anatomy in motion so clinicians can interpret the dynamic interaction of anatomical structures, such as tissue and bone, with physiological changes over time.

Omeros Corporation (Nasdaq: OMER) today reported results from the narsoplimab arm of the I-SPY COVID Trial, sponsored by Quantum Leap Healthcare Collaborative (QLHC).

Select Medical announced that 16 of its inpatient rehabilitation hospitals have been named to Newsweek’s 2022 list of America’s Best Physical Rehab Centers.

Medcura Inc. welcomes Steve Ford, its new Senior Vice President of Marketing and Business Development, whose two-plus decades of experience leading and contributing to over 75 product development teams, and launching more than 100 medical devices globally, helps position the commercial-stage life science and medical device company for broad market adoption and rapid platform expansion.

ProSomnus, a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced that the ProSomnus EVOTM Sleep and Snore Device is now reimbursable by Germany’s public health insurance system.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will present seven abstracts from across its neuroscience portfolio at the 35th annual Psych Congress 2022, being held September 17-20, 2022.

Know Labs, Inc., an emerging developer of non-invasive medical diagnostic technology, announced the pricing of a firm commitment underwritten public offering of 3,600,000 shares of its common stock at a public offering price of $2.00 per share.